Noninvasive Hemoglobin Testing, Prospective Blood Donors

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

131 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-06-23

Study Completion Date

2020-07-07

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The objective of this clinical investigation is to evaluate the pulse oximeter devices for screening prospective blood donors. The purpose study is to report on the accuracy of noninvasive hemoglobin (SpHb) as compared to hemoglobin measurements obtained from a laboratory hematology analyzer in a blood donation setting.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Noninvasive Hemoglobin Repeatability and Reproducibility in a Blood Donation Setting

NCT04490863

Healthy Anemia

COMPLETED NA

Accuracy of Noninvasive Hemoglobin Sensor (Rainbow Reusable DCI)

NCT03124758

Healthy

COMPLETED NA

Comparison of Noninvasive Hemoglobin Disposable Sensors

NCT03125031

Healthy

COMPLETED NA

Non-Invasive Hemoglobin Study

NCT02206399

Anemia

COMPLETED

NBM-200 Clinical Study in Blood Donation Setting

NCT05217576

Hemoglobin H

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy Anemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Test subjects

All subjects are enrolled and receive Rad-67 Pulse oximeter \& DCI Mini sensor for measurement of hemoglobin.

Group Type EXPERIMENTAL

Rad-67 Pulse oximeter & DCI Mini sensor

Intervention Type DEVICE

Noninvasive pulse oximeter that measures hemoglobin

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Rad-67 Pulse oximeter & DCI Mini sensor

Noninvasive pulse oximeter that measures hemoglobin

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* At least 18 years of age
* Weight at least 110 pounds
* Subjects with the intention of being screened for eligibility to donate blood
* The subject has given written informed consent to participate in the study

Exclusion Criteria

* Subjects with skin abnormalities at the planned application sites that may interfere with sensor application, per directions-for-use (DFU) or trans-illumination of the site, such as burns, scar tissue, infections, abnormalities, etc.
* Subjects unwilling and/or unable to remove nail polish or acrylic nails
* Subjects with blood cancers such as leukemia
* Subjects with hemoglobin disorders such as sickle-cell anemia and thalassemia
* Subjects with known history of infectious diseases such as HIV/AIDS, syphilis, hepatitis, etc.
* Subjects with self-disclosed/known pregnancy at the time of enrollment
* Subjects deemed not suitable for the study at the discretion of the investigator
* Excessive motion includes postural changes, making hand gestures, involuntary muscular movements, etc.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes